Fiduciary Planning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$559K Hold
608
0.17% 50
2025
Q4
$653K Buy
608
+18
+3% +$17.2K 0.2% 48
2025
Q3
$450K Buy
590
+6
+1% +$4.46K 0.14% 53
2025
Q2
$455K Buy
584
+65
+13% +$50.5K 0.15% 52
2025
Q1
$428K Buy
519
+16
+3% +$13.3K 0.14% 52
2024
Q4
$389K Buy
+503
New +$416K 0.13% 56
2024
Q3
Sell
-318
Closed -$288K 62
2024
Q2
$288K Buy
+318
New +$254K 0.1% 53

Other funds holding LLY

Fiduciary Planning's LLY Position: Q1 2026 in Review

Fiduciary Planning held its Eli Lilly (LLY) position steady in Q1 2026 at 608 shares worth $559K. The position accounts for 0.17% of the portfolio, ranked #50.

Fiduciary Planning first reported a position in LLY in Q2 2024 and has held it in 7 quarters since. The position peaked at $653K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Fiduciary Planning held 608 shares of Eli Lilly worth $559K as of Q1 2026.
  • Fiduciary Planning left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.17% of Fiduciary Planning's portfolio in Q1 2026, its #50 holding.
  • Fiduciary Planning first reported a position in Eli Lilly in Q2 2024 and has held it in 7 quarters since.
  • Fiduciary Planning's Eli Lilly position peaked at $653K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Fiduciary Planning's 13F filing for Q1 2026, filed 27 Apr 2026.